Shine-On BioMedical Co.,Ltd. (6926.TWO)
TWD 60.0
(0.0%)
TWD 60.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -101.48 Million TWD | 72.69% |
| 2022 | -371.64 Million TWD | 54.81% |
| 2021 | -822.31 Million TWD | 0.0% |
| 2020 | - TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -40.27 Million TWD | 3.06% |
| 2024 Q1 | -40.27 Million TWD | 60.31% |
| 2023 Q1 | -362.05 Million TWD | 2.58% |
| 2023 Q3 | -102.02 Million TWD | 71.74% |
| 2023 Q2 | -361.07 Million TWD | 0.27% |
| 2023 FY | -101.48 Million TWD | 72.69% |
| 2023 Q4 | -101.48 Million TWD | 0.53% |
| 2022 Q3 | -372.18 Million TWD | 0.0% |
| 2022 Q4 | -371.64 Million TWD | 0.14% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 61.583% |
| Level Biotechnology Inc. | -453.9 Million TWD | 77.642% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 15.828% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 48.326% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 120.303% |
| GlycoNex Incorporation | -148.56 Million TWD | 31.69% |
| VBI | -25.31 Million TWD | -300.877% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 352.039% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 173.543% |
| Visgeneer Inc. | 31.28 Million TWD | 424.402% |
| Mycenax Biotech Inc. | 207 Million TWD | 149.025% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 85.089% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 24.406% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 116.328% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -76.014% |
| Enimmune corporation | -314.15 Million TWD | 67.696% |
| TaiRx, Inc. | -147.86 Million TWD | 31.368% |
| CHO Pharma, Inc. | -203.79 Million TWD | 50.201% |
| EirGenix Inc. | -4.58 Billion TWD | 97.788% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -19.729% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 183.962% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 96.846% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 68.028% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -412.219% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 419.048% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 299.953% |
| RBC Bioscience Corporation | 422.18 Million TWD | 124.038% |
| BiOptic Inc. | 12.59 Million TWD | 905.956% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 89.254% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 38.559% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 132.231% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -31.725% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 61.351% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 431.892% |
| Neith Corporation | -150.31 Million TWD | 32.483% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -57.781% |
| NaviFUS Corp. | -123.12 Million TWD | 17.578% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 237.049% |
| Sinew Pharma Inc. | -160.34 Million TWD | 36.708% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 58.045% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 69.919% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 75.406% |
| AP Biosciences Inc | -196.52 Million TWD | 48.361% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 114.735% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -787.348% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 87.768% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 107.477% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 75.538% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 51.521% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 29.456% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 69.297% |
| TCI GENE Inc. | -689.25 Million TWD | 85.276% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 14.673% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 92.248% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 595.465% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 0.377% |
| PharmaEngine, Inc. | -860.8 Million TWD | 88.21% |
| Savior Lifetec Corporation | -812.54 Million TWD | 87.51% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 66.168% |
| OBI Pharma, Inc. | -398.22 Million TWD | 74.515% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 72.227% |
| Acepodia, Inc. | -6.02 Billion TWD | 98.314% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 97.017% |